Insight: DePuy’s handling of hip recall sparks questions

BOSTON (Reuters) – Johnson & Johnson, which could face billions of dollars in costs over an artificial hip recall, is taking an scarce approach to managing the crisis — one that could regulate its financial exposure, legal experts say.




View full post on Reuters: Business News

Share and Enjoy:
  • Print this article!
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks

Leave a Reply


Powered by Yahoo! Answers